Literature DB >> 27692178

The Calcium-Sensing Receptor in Health and Disease.

G Díaz-Soto1, A Rocher2, C García-Rodríguez3, L Núñez2, C Villalobos4.   

Abstract

The extracellular calcium-sensing receptor (CaSR) is a unique G protein-coupled receptor (GPCR) activated by extracellular Ca2+ and by other physiological cations including Mg2+, amino acids, and polyamines. CaSR is the most important master controller of the extracellular Ca2+ homeostatic system being expressed at high levels in the parathyroid gland, kidney, gut and bone, where it regulates parathyroid hormone (PTH) secretion, vitamin D synthesis, and Ca2+ absorption and resorption, respectively. Gain and loss of function mutations in the CaSR are responsible for severe disturbances in extracellular Ca2+ metabolism. CaSR agonists (calcimimetics) and antagonists (calcilytics) are in use or under intense research for treatment of hyperparathyroidism secondary to kidney failure and hypocalcemia with hypercalciuria, respectively. Expression of the CaSR extends to other tissues and systems beyond the extracellular Ca2+ homeostatic system including the cardiovascular system, the airways, and the nervous system where it may play physiological functions yet to be fully understood. As a consequence, CaSR has been recently involved in different pathologies including uncontrolled blood pressure, vascular calcification, asthma, and Alzheimer's disease. Finally, the CaSR has been shown to play a critical role in cancer either contributing to bone metastasis and/or acting as a tumor suppressor in some forms of cancer (parathyroid cancer, colon cancer, and neuroblastoma) and as oncogene in others (breast and prostate cancers). Here we review the role of CaSR in health and disease in calciotropic tissues and others beyond the extracellular calcium homeostatic system.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; asthma; calcium; calcium-sensing receptor; cancer; cardiovascular disease; hyperparathyroidism

Mesh:

Substances:

Year:  2016        PMID: 27692178     DOI: 10.1016/bs.ircmb.2016.05.004

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  16 in total

1.  Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.

Authors:  Hao Li; Jing-Wei Liu; Shuang Liu; Yuan Yuan; Li-Ping Sun
Journal:  Dig Dis Sci       Date:  2017-09-15       Impact factor: 3.199

2.  A curious case of growth failure and hypercalcemia: Answers.

Authors:  Mallory L Downie; Jaap Mulder; Rayfel Schneider; Lillian Lim; Nasrin Tehrani; Jonathan D Wasserman; Shai Fuchs; Rohan John; Damien G Noone; Diane Hebert
Journal:  Pediatr Nephrol       Date:  2017-08-07       Impact factor: 3.714

Review 3.  Familial hypocalciuric hypercalcemia and related disorders.

Authors:  Janet Y Lee; Dolores M Shoback
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-05-26       Impact factor: 4.690

4.  Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.

Authors:  Noriko Makita; Takao Ando; Junichiro Sato; Katsunori Manaka; Koji Mitani; Yasuko Kikuchi; Takayoshi Niwa; Masanori Ootaki; Yuko Takeba; Naoki Matsumoto; Atsushi Kawakami; Toshihisa Ogawa; Masaomi Nangaku; Taroh Iiri
Journal:  JCI Insight       Date:  2019-04-18

5.  Novel mutations of the calcium-sensing receptor impede differential diagnosis of primary hyperparathyroidism and familial hypocalciuric hypercalcemia.

Authors:  Jagdeep Singh Bhangu; Sabina Baumgartner-Parzer; Lindsay Hargitai; Peter Mazal; Christian Scheuba; Philipp Riss
Journal:  Gland Surg       Date:  2022-01

6.  Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.

Authors:  Fatemeh Momen-Heravi; Yohei Masugi; Zhi Rong Qian; Reiko Nishihara; Li Liu; Stephanie A Smith-Warner; NaNa Keum; Lanjing Zhang; Nairi Tchrakian; Jonathan A Nowak; Wanshui Yang; Yanan Ma; Michaela Bowden; Annacarolina da Silva; Molin Wang; Charles S Fuchs; Jeffrey A Meyerhardt; Kimmie Ng; Kana Wu; Edward Giovannucci; Shuji Ogino; Xuehong Zhang
Journal:  Int J Cancer       Date:  2017-09-20       Impact factor: 7.396

7.  Exosomal transfer of miR-429 confers chemoresistance in epithelial ovarian cancer.

Authors:  Taoqiong Li; Li Lin; Qin Liu; Wujiang Gao; Lu Chen; Chunli Sha; Qi Chen; Wenlin Xu; Yuefeng Li; Xiaolan Zhu
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 8.  Class C GPCRs in the airway.

Authors:  Brijeshkumar S Patel; Jovanka Ravix; Christina Pabelick; Y S Prakash
Journal:  Curr Opin Pharmacol       Date:  2020-05-04       Impact factor: 5.547

Review 9.  Genetics of Magnesium Disorders.

Authors:  Heng Li; Shiren Sun; Jianghua Chen; Goushuang Xu; Hanmin Wang; Qi Qian
Journal:  Kidney Dis (Basel)       Date:  2017-07-05

10.  A NOVEL MUTATION IN CALCIUM-SENSING RECEPTOR PRESENTING AS FAMILIAL HYPOCALCIURIC HYPERCALCEMIA IN A YOUNG MAN.

Authors:  Parvathy Madhavan; Thi Hong Van Do; Allen Bale; Sachin Majumdar
Journal:  AACE Clin Case Rep       Date:  2019-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.